ADBE vs MRK: Which Is the Better Buy?

Side-by-side comparison of Adobe Inc. and Merck & Co., Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-23.
Adobe Inc. ยท Technology
$238.25
+13.5% upside to fair value
Med Conviction Grade B High Quality
VS
Merck & Co., Inc. ยท Healthcare
$147.17
-4.1% upside to fair value
Med Conviction Grade C
QuantHub Verdict
ADBE has more upside to fair value (+13.5%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric ADBE MRK
Current Price $238.25 $147.17
Fair Value Estimate $270.38 $141.07
Upside to Fair Value +13.5% -4.1%
Market Cap $94.7B $363.5B
Forward P/E โ€” โ€”
EV / EBITDA 9.5x 29.6x
Price / Sales 3.6x 5.5x
Price / FCF 8.6x 22.6x
Revenue Growth YoY +12.9% +5.1%
Gross Margin 89.1% 75.4%
Operating Margin 35.7% 16.7%
Return on Equity 62.9% 6.6%
Dividend Yield 0% 2.31%
FCF Yield 11.63% 4.42%
Analyst Consensus Hold Buy
Investment Thesis
ADBE โ€” Adobe Inc.
Adobe is a global software provider organized into Digital Media, Digital Experience, and Publishing and Advertising, with Creative Cloud as its subscription flagship and Document Cloud as its cloud-native document platform. The business quality is high on fundamentals: TTM gross margin of 89.1%, TTM operating margin of 35.7%, TTM net margin of 28.0%, ROE of 62.9%, and free cash flow of $27.69 peโ€ฆ
MRK โ€” Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely higโ€ฆ
Accumulation Zones
Metric ADBE MRK
Zone Low $202.78 $105.80
Zone High $229.82 $119.91
In Buy Zone? No No
โ† ADBE Research    MRK Research โ†’    All Research